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Zelnate on Arrival Could Decrease the Likelihood of Subsequent Pulls in Suspect
Bovine Respiratory Disease Complex Cases
Abstract
Antimicrobial metaphylaxis is an important tool used for the prevention of Bovine Respiratory Disease
Complex; a disease with a large economic impact that typically affects newly-weaned beef calves that are
marketed and transported a distance from their origin.
There are questions involving the potential benefit of Zelnate, a novel non-antibiotic technology designed
to activate an animal’s natural immunity to fight Bovine Respiratory Disease Complex, being used either
solely or in combination with metaphylaxis at the time of initial processing of high risk calves. More
knowledge is also needed regarding the possible effects of repeated use of Zelnate when subsequent
therapy is required in individual Bovine Respiratory Disease Complex cases. The objective of this study
was to evaluate the effectiveness of Zelnate when used as part of an antimicrobial metaphylaxis
treatment or when used in combination with an antibiotic when a calf is diagnosed with Bovine
Respiratory Disease Complex.
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Zelnate on Arrival Could Decrease the
Likelihood of Subsequent Pulls in Suspect
Bovine Respiratory Disease Complex Cases
T.J. Spore, S.P. Montgomery, G.A. Hanzlicek, W.R. Hollenbeck, R.N. Wahl,
J.E. Sears1, and D.A. Blasi

Introduction

Antimicrobial metaphylaxis is an important tool used for the prevention of Bovine
Respiratory Disease Complex; a disease with a large economic impact that typically affects newly-weaned beef calves that are marketed and transported a distance from their
origin.
There are questions involving the potential benefit of Zelnate, a novel non-antibiotic
technology designed to activate an animal’s natural immunity to fight Bovine Respiratory Disease Complex, being used either solely or in combination with metaphylaxis at
the time of initial processing of high risk calves. More knowledge is also needed regarding the possible effects of repeated use of Zelnate when subsequent therapy is required
in individual Bovine Respiratory Disease Complex cases. The objective of this study was
to evaluate the effectiveness of Zelnate when used as part of an antimicrobial metaphylaxis treatment or when used in combination with an antibiotic when a calf is diagnosed
with Bovine Respiratory Disease Complex.
Key words: Zelnate, high risk, bovine respiratory disease

Experimental Procedures

During a four-day period (October 6-9, 2015) three semi-loads containing 283 head of
high-risk cross-bred heifers (520 ± 39 lb) were purchased from sale barns in Tennessee and Alabama, assembled at a Dickson, Tennessee order buyer facility, and shipped
to the Kansas State University Beef Stocker Unit. After initial processing the animals
were placed in temporary pens with each truck representing six pens with free access to
native grass hay and water through automatic waterers. The morning after arrival, calves
were vaccinated for common clostridial and viral diseases (Pyramid 5 + Presponse,
Vetmedica, St. Joseph, MO; Excede, Zoetis, Parsippany, NJ; Vison 7 with Somnus,
Merck Animal Health, Madison, NJ); dewormed (Safeguard, Merck Animal Health,
Madison, NJ); treated for flies (Permectrin CDS; Bayer, Shawnee Mission, KS); and
implanted with a mild growth implant (Revalor IH, Merck Animal Health, Madison,
1
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NJ). One half of the calves also received 2 ml intramuscular of Zelnate (Bayer Healthcare, Animal Health Division, Shawnee Mission, KS) at this time. Calves were blocked
by load and initially assigned to six pens based on arrival weight. To maintain similar
weights between initial treatments (receiving Zelnate or not at arrival), after animals
were sorted by weight, the heaviest animal in the pen was assigned group no Zelnate
and the next heaviest group received Zelnate at initial processing. This procedure was
replicated through each pen to standardize weights between arrival groups. A second
population of treatments was generated based on rectal temperature as the animals were
visually pulled for illness. Calves that had a rectal temperature of greater than or equal
to 104°F at first pull received Baytril 100 (Bayer Healthcare, Animal Health Division,
Shawnee Mission, KS) (Bovine Respiratory Disease, no Zelnate at pull) or Baytril 100
and Zelnate (Bovine Respiratory Disease, Zelnate at pull). Similarly, calves that did not
have a rectal temperature of 104°F were either not treated at all (respiratory observed,
no Zelnate) or administered only Zelnate (respiratory observed, Zelnate). The combination of treatment group on arrival and treatment at first pull for illness yielded eight
possible treatments for cattle that were pulled and two for cattle that were never pulled.
All animals enrolled in the study were fed an identical diet once daily at approximately
7:00 a.m. (Table 1). Feed bunks were checked once daily and adjustments made in
delivery to ensure feed bunks were slick at the next feeding. All calves were checked at
least once daily to assess animal health. Performance data were analyzed using standard
T-test for mean comparison and ANOVA in StatPlus (Version 6; AnalystSoft Inc.).
Health data were analyzed using proportion comparisons of morbidity in Stata 12
(StataCorp., 2011).

Results and Discussion

The results from the study are below in Tables 2, 3, 4, and 5. The administration of Zelnate upon arrival had no statistical effect on initial pull (P=0.92) or average daily gain
(P=0.34). Although there were no statistical differences in morbidity 2 (second pull)
between any of the treatments, calves that received Zelnate on arrival but not at first
treatment for suspect cases of Bovine Respiratory Disease Complex (Zelnate at arrival,
respiratory observed, no Zelnate at pull) appeared to be less likely to experience subsequent pulls compared to those animals receiving Zelnate only at treatment for Bovine
Respiratory Disease Complex (no Zelnate at arrival, respiratory observed, Zelnate at
pull) (P=0.06). Furthermore, average daily gain of calves that received Zelnate on arrival and not as a component of Bovine Respiratory Disease Complex therapy (Zelnate
at arrival, no Zelnate at pull) appeared to be higher; however, the difference was not
statistically significant (P=0.8).

Implications

These results suggest that Zelnate used only in combination with metaphylaxis on arrival and not as a component of Bovine Respiratory Disease Complex treatment could
decrease the likelihood of additional pulls in suspect Bovine Respiratory Disease Complex cases. Additional research opportunities may exist in addressing the effectiveness of
Zelnate used as pre-shipping treatment, particularly as calves are loaded on trucks at the
order buyer/auction market facilities prior to transportation.
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Table 1. Experimental diet fed
Experimental diet
Ingredient
Dry rolled corn
Control supplement
Steep
Alfalfa hay
Prairie hay
Corn germ meal
Distillers dried grains
Total

% of dry matter
28.13
5.63
10.00
17.50
17.50
11.25
10.00
100.00

Calculated nutrient content
Dry matter, %
Protein, %
Calcium, %
Phosphorus, %
Salt, %
Potassium, %
Magnesium, %
Fat, %
Acid detergent fiber, %
Net energy gain, Mcal/cwt

81.8
16.92
0.80
0.52
0.28
1.20
0.25
3.40
18.22
48.68

Table 2. Proportion of calves initially pulled for illness from each treatment
Arrival treatment
1st pull rate
P-value
No Zelnate
39%
0.92
Received Zelnate at initial processing
39%

Table 3. Healthy cattle performance
Arrival treatment
Final average daily gain, lb
No Zelnate
3.23
Received Zelnate at initial processing
3.27

P-value
0.34
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Table 4. Proportion of calves pulled twice from each treatment combination
Bovine Respiratory Disease cases
2nd pull rate
No Zelnate at arrival / no Zelnate at first pull
35%
No Zelnate at arrival / Zelnate given at first pull
54%
Zelnate at arrival / no Zelnate at first pull
44%
Zelnate at arrival / Zelnate given at first pull
33%
Respiratory observed, no fever cases
No Zelnate at arrival / no Zelnate at first pull
No Zelnate at arrival / Zelnate given at first pull
Zelnate at arrival / no Zelnate at first pull
Zelnate at arrival / Zelnate given at first pull
ab

2nd pull rate
44%ab
50%a
11%b
36%ab

Means in a column with uncommon superscripts differ.

Table 5. Morbid cattle performance
Arrival treatment/pull treatment
No Zelnate at arrival / no Zelnate at first pull
No Zelnate at arrival / Zelnate given at first pull
Zelnate at arrival / no Zelnate at first pull
Zelnate at arrival / Zelnate given at first pull

Final average daily gain, lb
2.73
2.46
2.86
2.71

P-value
0.80
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